Arrhythmias & electrophysiology

Bleeding, stroke, and mortality risk of patients with septic shock receiving anticoagulation for atrial fibrillation

Heart RhythmPublished Retrospective cohort study

Authors' conclusion

In patients with septic shock and AF, AC was not associated with a higher incidence of bleeding or lowering of in-hospital strokes but was associated with decreased mortality, potentially protecting against disseminated intravascular coagulopathy or other embolic phenomena.

Study context

Population
Hospitalised patients with septic shock and atrial fibrillation (AF) (subgroup: new-onset AF)
Participants
604 patients
Exposure
Therapeutic anticoagulation vs no anticoagulation
Outcome
In-hospital stroke and significant bleeding
Methodological detailssingle-centre, propensity-score matched
  • Single-centre
  • Propensity-score matched

Main finding

As reported in the abstract

AC vs Without ACRelative risk (95% CI)
Bleeding, AF
1.33(0.81–2.17)
Bleeding, new-onset AF
1.60(0.72–3.54)

Observational data: associations, not effects.

Further findings

Mortality · AF · propensity score-matched cohorts

P = 0.01

Mortality · new-onset AF · propensity score-matched cohorts

P = 0.04

Safety

OutcomeRR (95% CI)
Bleeding (BARC 2 and 3a most common)ACvs Without ACAF1.33 (0.81–2.17)
Bleeding (BARC 2 and 3a most common)ACvs Without ACNew-onset AF1.60 (0.72–3.54)

Original publication

Bleeding, stroke, and mortality risk of patients with septic shock receiving anticoagulation for atrial fibrillation. Heart Rhythm. Published 6 December 2024. doi:10.1016/j.hrthm.2024.12.001

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.